SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Bhatt Samir) "

Sökning: WFRF:(Bhatt Samir)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Kassebaum, Nicholas J., et al. (författare)
  • Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
  • 2016
  • Ingår i: The Lancet. - 0140-6736 .- 1474-547X. ; 388:10053, s. 1603-1658
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate how disease burden changes with development. Methods We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2015. We calculated DALYs by summing years of life lost (YLLs) and years of life lived with disability (YLDs) for each geography, age group, sex, and year. We estimated HALE using the Sullivan method, which draws from age-specific death rates and YLDs per capita. We then assessed how observed levels of DALYs and HALE differed from expected trends calculated with the Socio-demographic Index (SDI), a composite indicator constructed from measures of income per capita, average years of schooling, and total fertility rate. Findings Total global DALYs remained largely unchanged from 1990 to 2015, with decreases in communicable, neonatal, maternal, and nutritional (Group 1) disease DALYs off set by increased DALYs due to non-communicable diseases (NCDs). Much of this epidemiological transition was caused by changes in population growth and ageing, but it was accelerated by widespread improvements in SDI that also correlated strongly with the increasing importance of NCDs. Both total DALYs and age-standardised DALY rates due to most Group 1 causes significantly decreased by 2015, and although total burden climbed for the majority of NCDs, age-standardised DALY rates due to NCDs declined. Nonetheless, age-standardised DALY rates due to several high-burden NCDs (including osteoarthritis, drug use disorders, depression, diabetes, congenital birth defects, and skin, oral, and sense organ diseases) either increased or remained unchanged, leading to increases in their relative ranking in many geographies. From 2005 to 2015, HALE at birth increased by an average of 2.9 years (95% uncertainty interval 2.9-3.0) for men and 3.5 years (3.4-3.7) for women, while HALE at age 65 years improved by 0.85 years (0.78-0.92) and 1.2 years (1.1-1.3), respectively. Rising SDI was associated with consistently higher HALE and a somewhat smaller proportion of life spent with functional health loss; however, rising SDI was related to increases in total disability. Many countries and territories in central America and eastern sub-Saharan Africa had increasingly lower rates of disease burden than expected given their SDI. At the same time, a subset of geographies recorded a growing gap between observed and expected levels of DALYs, a trend driven mainly by rising burden due to war, interpersonal violence, and various NCDs. Interpretation Health is improving globally, but this means more populations are spending more time with functional health loss, an absolute expansion of morbidity. The proportion of life spent in ill health decreases somewhat with increasing SDI, a relative compression of morbidity, which supports continued efforts to elevate personal income, improve education, and limit fertility. Our analysis of DALYs and HALE and their relationship to SDI represents a robust framework on which to benchmark geography-specific health performance and SDG progress. Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform financial and research investments, prevention efforts, health policies, and health system improvement initiatives for all countries along the development continuum.
  •  
3.
  • Mehrjou, Arash, et al. (författare)
  • Pyfectious : An individual-level simulator to discover optimal containment policies for epidemic diseases
  • 2023
  • Ingår i: PloS Computational Biology. - : Public Library of Science (PLoS). - 1553-734X .- 1553-7358. ; 19:1, s. e1010799-
  • Tidskriftsartikel (refereegranskat)abstract
    • Author summaryPyfectious is an agent-based simulator with the capability to serve as an environment for reinforcement learning agents to discover novel control high-resolution agent-based policies that are hard for humans to discover. Pyfectious introduces several novelties which are unprecedented in the existing popular simulators in epidemiology. It constructs the population structure of a city without needing too detailed information by a novel probabilistic assignment method that is unparalleled to existing population synthesizers. The proposed disease propagation algorithm offers a multi-resolution functionality that allows running Pyfectious for large-population cities on normal computers. The modeling details can be easily traded-off with computational demand requiring minimal effort by the end user. The control and monitoring components are designed in an event-triggered fully flexible way by providing a rich action space from which effective policies are hoped to be discovered by advanced RL methods which are otherwise impossible for humans to find due to the immense complexity of the problem. An extensive set of experiments are included to illustrate various aspects of Pyfectious and also to briefly showcase its use as an RL environment which is hoped to help the automatic discovery of epidemic control policies upon bringing together RL scientists and epidemiologists. Simulating the spread of infectious diseases in human communities is critical for predicting the trajectory of an epidemic and verifying various policies to control the devastating impacts of the outbreak. Many existing simulators are based on compartment models that divide people into a few subsets and simulate the dynamics among those subsets using hypothesized differential equations. However, these models lack the requisite granularity to study the effect of intelligent policies that influence every individual in a particular way. In this work, we introduce a simulator software capable of modeling a population structure and controlling the disease's propagation at an individualistic level. In order to estimate the confidence of the conclusions drawn from the simulator, we employ a comprehensive probabilistic approach where the entire population is constructed as a hierarchical random variable. This approach makes the inferred conclusions more robust against sampling artifacts and gives confidence bounds for decisions based on the simulation results. To showcase potential applications, the simulator parameters are set based on the formal statistics of the COVID-19 pandemic, and the outcome of a wide range of control measures is investigated. Furthermore, the simulator is used as the environment of a reinforcement learning problem to find the optimal policies to control the pandemic. The obtained experimental results indicate the simulator's adaptability and capacity in making sound predictions and a successful policy derivation example based on real-world data. As an exemplary application, our results show that the proposed policy discovery method can lead to control measures that produce significantly fewer infected individuals in the population and protect the health system against saturation.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (3)
Typ av innehåll
refereegranskat (3)
Författare/redaktör
Larsson, Anders (2)
Mitchell, Philip B (2)
McKee, Martin (2)
Koyanagi, Ai (2)
Zaidi, Zoubida (2)
Koul, Parvaiz A. (2)
visa fler...
Gething, Peter W. (2)
Schutte, Aletta E. (2)
Afshin, Ashkan (2)
Cornaby, Leslie (2)
Abbafati, Cristiana (2)
Badawi, Alaa (2)
Bensenor, Isabela M. (2)
Bernabe, Eduardo (2)
Dandona, Lalit (2)
Dandona, Rakhi (2)
Esteghamati, Alireza (2)
Farzadfar, Farshad (2)
Feigin, Valery L. (2)
Fernandes, Joao C. (2)
Geleijnse, Johanna M ... (2)
Hamidi, Samer (2)
Harikrishnan, Sivada ... (2)
Jonas, Jost B. (2)
Kasaeian, Amir (2)
Khader, Yousef Saleh (2)
Khalil, Ibrahim A. (2)
Khang, Young-Ho (2)
Kokubo, Yoshihiro (2)
Kumar, G. Anil (2)
Lopez, Alan D. (2)
Lotufo, Paulo A. (2)
Lozano, Rafael (2)
Malekzadeh, Reza (2)
Mendoza, Walter (2)
Miller, Ted R. (2)
Mokdad, Ali H. (2)
Naghavi, Mohsen (2)
Pereira, David M. (2)
Qorbani, Mostafa (2)
Rai, Rajesh Kumar (2)
Roshandel, Gholamrez ... (2)
Roth, Gregory A. (2)
Sartorius, Benn (2)
Sepanlou, Sadaf G. (2)
Sorensen, Reed J. D. (2)
Tran, Bach Xuan (2)
Tyrovolas, Stefanos (2)
Uthman, Olalekan A. (2)
Vollset, Stein Emil (2)
visa färre...
Lärosäte
Uppsala universitet (2)
Lunds universitet (2)
Karolinska Institutet (2)
Högskolan Dalarna (2)
Göteborgs universitet (1)
Umeå universitet (1)
visa fler...
Kungliga Tekniska Högskolan (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (2)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy